A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's

Tornling, G., Edenius, C., Pauling, J. D., Denton, C. P., Olsson, A., Kowalski, J., Murray, A., Anderson, M., Bhat, S., Del Galdo, F., Hall, F., Korkosz, M., Krasowska, D., Olas, J., Smith, V., van Laar, J. M., Vonk, M. C., Wojteczek, A. & Herrick, A. L., 30/01/2024, (E-pub ahead of print) In: Rheumatology.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS)

Griffiths-Jones, D. J., Garcia, Y. S., Ryder, W. D., Pauling, J. D., Hall, F., Lanyon, P., Bhat, S., Douglas, K., Gunawardena, H., Akil, M., Anderson, M., Griffiths, B., Del Galdo, F., Youssef, H., Madhok, R., Arthurs, B., Buch, M., Fligelstone, K., Zubair, M., Mason, J. C., & 2 othersDenton, C. P. & Herrick, A. L., 30/09/2023, In: Rheumatology. 62, 9, p. 3133-3138 6 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

A systematic review exploring pre-COVID-19 telehealthcare models used in the management of patients with rheumatological disease

Nelson, A. J. & Anderson, M. E., 30/11/2021, In: Rheumatology Advances in Practice. 5, 3, 14 p., rkab073.

Research output: Contribution to Journal/Magazine › Journal article › peer-review